MediSapiens

19/04/2022

Real-time medicine in combination with , read our article: https://bit.ly/3cjJer4

Genomic medicine may facilitate predictive, preventive and personalized (or precision) health care, improve cost efficiency of medical care and promote

14/04/2022

MediSapiens team wish everyone a very Happy Easter! :)

18/01/2022

We are proud to announce the release of our 1.2 version of our Genomics Software Suite (GSS)! The 1.2 version provides an evolution in the capabilities for data-driven and application with , , researchers, and operators

Read more about it here: https://bit.ly/3bZXmpA

MediSapiens is excited to launch the evolution of its Genomics Software Suite (GSS), version 1.2.

11/01/2022

Real-time medicine in combination with , read our latest article: https://bit.ly/3cjJer4

Genomic medicine may facilitate predictive, preventive and personalized (or precision) health care, improve cost efficiency of medical care and promote

01/01/2022

Happy New Year from the MediSapiens team!

#2022

21/12/2021

The MediSapiens team wishes you a very pleasant, relaxed, safe and happy holiday season! We look forward to work with you again in 2022 and share some exciting new developments with you.

23/11/2021

Our quarterly newsletter will come out next week. If you have not yet subscribed yet, contact us via our medisapiens.com website!

MediSapiens provides software solutions to clients in the biomedical field. Our solutions turn biomedical data into new insights and knowledge. Our clients

21/10/2021

We are very excited to announce our cooperation with Predicell in combining our genomics expertise with Predicell's wearable RWE capabilities. Our joint capabilities will benefit significantly, making data-driven decisions for clinicians much easier.

More info: https://bit.ly/3FQtCJr

MediSapiens and Predicell (Helsinki and Espoo, Finland) are excited to announce their cooperation in combining AI-driven solutions for (preventive) healthcare

21/09/2021

Did you already see the interview by DNA Weekly with our VP of Sales Hans Garritzen? It gives a nice impression of our work providing IT solutions for data-driven and : https://bit.ly/39XOJep

MediSapiens creates cutting-edge solutions for transforming biomedical data from different source into knowledge, insight, and value. In this interview, VP of Sales Hans Garritzen discusses the shift from reactive, generic healthcare into proactive, personalized healthcare, and the advantages for da...

20/07/2021

MediSapiens is a proud participant in Bayer pharma's Future Clinical Trials program, implemented in Finland to aiming to improve practices worldwide.
We support Bayer with our and knowhow to ensure between different data sources.

Read more here in Bayer's latest press release: https://www.bayer.com/en/fi/finnish-project-renews-pharmaceutical-research

Pharmaceuticals focuses on prescription drugs for the therapeutic areas of cardiology, oncology, gynecology, hematology & ophthalmology.

30/06/2021

MediSapiens and VEIL.AI are excited to announce their cooperation in launching an innovative process for the anonymization and of clinical data.

This joint process addresses the need for clinical data to be fully compliant with local regulations, yet without losing valuable information during the process and be compatible with data from other sources.

Read more here: https://bit.ly/3grD366